Vicarious Surgical (Vicarious Surgical) 5-Year EBITDA Growth Rate

: 0.00% (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

Vicarious Surgical's EBITDA per Share for the three months ended in Dec. 2023 was $-0.07.

During the past 12 months, Vicarious Surgical's average EBITDA Per Share Growth Rate was -1029.40% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was -64.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 4 years, the highest 3-Year average EBITDA Per Share Growth Rate of Vicarious Surgical was -64.20% per year. The lowest was -64.20% per year. And the median was -64.20% per year.

Competitive Comparison

For the Medical Devices subindustry, Vicarious Surgical's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Vicarious Surgical 5-Year EBITDA Growth Rate Distribution

For the Medical Devices & Instruments industry and Healthcare sector, Vicarious Surgical's 5-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Vicarious Surgical's 5-Year EBITDA Growth Rate falls into.

Vicarious Surgical 5-Year EBITDA Growth Rate Calculation

This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Vicarious Surgical (NYSE:RBOT) 5-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.

Vicarious Surgical 5-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Vicarious Surgical's 5-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Vicarious Surgical (Vicarious Surgical) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Vicarious Surgical Inc (NYSE:RBOT) » Definitions » 5-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

78 Fourth Avenue, Waltham, MA, USA, 02451

Website

https://www.vicarioussurgical.com

Vicarious Surgical Inc designs a surgical robot that enables surgeons to perform minimally invasive surgery with 3D visualization and accurate control. Its Vicarious Surgical Robotic System is designed with a focus on abdominal access and visualization through a single port.

Executives

William John Kelly	officer: CFO and Treasurer	C/O VICARIOUS SURGICAL INC., 78 4TH AVENUE, WALTHAM MA 02451
Adam David Sachs	director, 10 percent owner, officer: President and CEO	C/O VICARIOUS SURGICAL INC., 78 4TH AVENUE, WALTHAM MA 02451
Sammy Khalifa	director, 10 percent owner, officer: Chief Technology Officer	C/O VICARIOUS SURGICAL INC., 78 4TH AVENUE, WALTHAM MA 02451
June Morris	officer: CLO, General Counsel and Sec	C/O VICARIOUS SURGICAL INC., 78 4TH AVENUE, WALTHAM MA 02451
John Mazzola	officer: Chief Operating Officer	TRANSMEDICS INC, 200 MINUTEMAN ROAD, ANDOVER MA 01810
Khosla Ventures Opportunity Associates Ii, Llc	10 percent owner	2128 SAND HILL ROAD, MENLO PARK CA 94025
Khosla Ventures V, L.p.	10 percent owner	2128 SAND HILL ROAD, MENLO PARK CA 94025
Khosla Ventures Opportunity Ii, L.p.	10 percent owner	2128 SAND HILL ROAD, MENLO PARK CA 94025
David D Ho	director	UNIT 1008, 10/F, CHAMPION TOWER, 3 GARDEN ROAD, CENTRAL K3 00000
Philip Liang	director	C/O VICARIOUS SURGICAL INC., 78 4TH AVENUE, WALTHAM MA 02451
Brendel Victoria Carr	director	C/O VICARIOUS SURGICAL, INC., 78 FOURTH AVENUE, WALTHAM MA 02451
Beverly A Huss	director	C/O ACCURAY INCORPORATED, 1310 CHESAPEAKE TERRACE, SUNNYVALE CA 94089
E15 Fund Ii, Lp	other: Sole Shareholder	C/O VICARIOUS SURGICAL INC., 78 4TH AVENUE, WALTHAM MA 02451
Shrikant Patnaik	other: Principal	C/O VICARIOUS SURGICAL INC., 78 4TH AVENUE, WALTHAM MA 02451
Ric Fulop	director	C/O DESKTOP METAL, INC., 63 THIRD AVENUE, BURLINGTON MA 01803